Molecular Changes in the Ki-ras and APC Genes in Primary Colorectal Carcinoma and Synchronous Metastases Compared with the Findings in Accompanying Adenomas

Overview

Journal Mol Pathol

Specialty Molecular Biology

Date 2003 Jun 5

PMID 12782759

Citations 27

Authors

P Zauber

M Sabbath-Solitare

S P Marotta

D T Bishop

Affiliations

Soon will be listed here.

Abstract

Aims: To compare the molecular genetic changes in the Ki-ras and adenomatous polyposis coli (APC) genes between colorectal carcinomas and synchronous metastases, and then to compare and contrast those changes with previously reported changes in the two genes between these carcinomas and accompanying adenomas. This expanded comparison would provide greater understanding of the progression of molecular changes in neoplastic tissue during the development of malignancy from a benign adenoma to carcinoma and then to metastatic spread of the malignancy.

Methods: DNA was extracted from paraffin wax embedded tissue. This was followed by polymerase chain reaction and gel electrophoresis for mutations in the Ki-ras gene using single stranded conformational polymorphism analysis. Amplification of a CA repeat marker was used to assess loss of heterozygosity (LOH) at the APC gene.

Results: The findings for the Ki-ras gene in 42 paired carcinomas and synchronous metastases were identical, regardless of whether or not the carcinoma and its companion adenoma had identical Ki-ras findings. The results of APC LOH for 39 paired carcinomas and synchronous metastases were also identical, whether or not the carcinoma and its companion adenoma had identical APC LOH findings. Results were uninformative for three pairs.

Conclusions: With respect to these two genes, a carcinoma may be discordant from its companion adenoma, but the metastasis remains consistent with the colonic carcinoma.

Citing Articles

The impact of RAS mutation on the treatment strategy of colorectal cancer.

Pirvu E, Severin E, Nita I, Toma S Med Pharm Rep. 2023; 96(1):5-15.

PMID: 36818322 PMC: 9924809. DOI: 10.15386/mpr-2408.

Report of two patients in whom comparisons of the somatic mutation profile were useful for the diagnosis of metastatic tumors.

Furukawa K, Hatakeyama K, Terashima M, Fujiya K, Tanizawa Y, Bando E Surg Case Rep. 2022; 8(1):214.

PMID: 36459241 PMC: 9718898. DOI: 10.1186/s40792-022-01566-8.

Colorectal cancers with a residual adenoma component: Clinicopathologic features and KRAS mutation.

Lee H, Song B, Kim K PLoS One. 2022; 17(9):e0273723.

PMID: 36083889 PMC: 9462729. DOI: 10.1371/journal.pone.0273723.

Discordance of KRAS Mutational Status between Primary Tumors and Liver Metastases in Colorectal Cancer: Impact on Long-Term Survival Following Radical Resection.

Ardito F, Razionale F, Salvatore L, Cenci T, Vellone M, Basso M Cancers (Basel). 2021; 13(9).

PMID: 33946899 PMC: 8125529. DOI: 10.3390/cancers13092148.

Biomarker concordance between primary colorectal cancer and its metastases.

Bhullar D, Barriuso J, Mullamitha S, Saunders M, ODwyer S, Aziz O EBioMedicine. 2019; 40:363-374.

PMID: 30733075 PMC: 6413540. DOI: 10.1016/j.ebiom.2019.01.050.

References

Muller A, Homey B, Soto H, Ge N, CATRON D, Buchanan M . Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001; 410(6824):50-6. DOI: 10.1038/35065016. View

Zauber N, Sabbath-Solitare M, Marotta S, Zauber A, Bishop D . Molecular changes in the Ki-ras and APC genes in colorectal adenomas and carcinomas arising in the same patient. J Pathol. 2001; 193(3):303-9. DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH813>3.0.CO;2-T. View

Fearon E, Vogelstein B . A genetic model for colorectal tumorigenesis. Cell. 1990; 61(5):759-67. DOI: 10.1016/0092-8674(90)90186-i. View

Spirio L, Joslyn G, Nelson L, Leppert M, White R . A CA repeat 30-70 KB downstream from the adenomatous polyposis coli (APC) gene. Nucleic Acids Res. 1991; 19(22):6348. PMC: 329171. DOI: 10.1093/nar/19.22.6348. View

Losi L, Benhattar J, Costa J . Stability of K-ras mutations throughout the natural history of human colorectal cancer. Eur J Cancer. 1992; 28A(6-7):1115-20. DOI: 10.1016/0959-8049(92)90468-h. View

Blaker H, Graf M, Rieker R, Otto H . Comparison of losses of heterozygosity and replication errors in primary colorectal carcinomas and corresponding liver metastases. J Pathol. 1999; 188(3):258-62. DOI: 10.1002/(SICI)1096-9896(199907)188:3<258::AID-PATH350>3.0.CO;2-9. View

Kang J, Essig Y, Mao W, Irby R, Wloch M, Yeatman T . Analysis of colorectal cancer by comparative genomic hybridization: evidence for induction of the metastatic phenotype by loss of tumor suppressor genes. Clin Cancer Res. 1998; 4(4):879-86. View

Zauber N, Bishop D . Ki-ras mutations in adenomas from cancer-bearing and cancer-free bowel. J Pathol. 1998; 184(3):340. DOI: 10.1002/(SICI)1096-9896(199803)184:3<340::AID-PATH14>3.0.CO;2-Y. View

Al-Mulla F, Going J, Sowden E, Winter A, Pickford I, BIRNIE G . Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality. J Pathol. 1998; 185(2):130-8. DOI: 10.1002/(SICI)1096-9896(199806)185:2<130::AID-PATH85>3.0.CO;2-M. View

10.

Al-Mulla F, Keith W, Pickford I, Going J, BIRNIE G . Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases. Genes Chromosomes Cancer. 1999; 24(4):306-14. DOI: 10.1002/(sici)1098-2264(199904)24:4<306::aid-gcc3>3.0.co;2-5. View

11.

Zauber N, Sabbath-Solitare M, Marotta S, Bishop D . K-ras mutation and loss of heterozygosity of the adenomatous polyposis coli gene in patients with colorectal adenomas with in situ carcinoma. Cancer. 1999; 86(1):31-6. DOI: 10.1002/(sici)1097-0142(19990701)86:1<31::aid-cncr6>3.0.co;2-o. View

12.

Finkelstein S, Sayegh R, Christensen S, Swalsky P . Genotypic classification of colorectal adenocarcinoma. Biologic behavior correlates with K-ras-2 mutation type. Cancer. 1993; 71(12):3827-38. DOI: 10.1002/1097-0142(19930615)71:12<3827::aid-cncr2820711207>3.0.co;2-n. View